HCID 58237949, compound → HCID 58237934, compound
Reaction equation
[Br:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]([N:10]2[CH2:15][CH2:14][C@@:13]([C:20]3[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=3)([CH2:16][CH2:17][CH2:18][OH:19])[CH2:12][C:11]2=[O:27])[CH3:9])=[CH:4][CH:3]=1.CC(C)=[O:30].OS(O)(=O)=O.O=[Cr](=O)=O>CC(C)=O.CCOC(C)=O>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C@@H:8]([N:10]2[CH2:15][CH2:14][C@:13]([CH2:16][CH2:17][C:18]([OH:30])=[O:19])([C:20]3[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=3)[CH2:12][C:11]2=[O:27])[CH3:9])=[CH:6][CH:7]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of (S)-1-((S)-1-(4-bromophenyl)ethyl)-4-(4-fluorophenyl)-4-(3-hydroxypropyl)piperidin-2-one (30 mg, 0.069 mmol) in acetone (2 mL) was added Jones reagent (0.3 mL, 2.5 M) at 0° C. The mixture was stirred for 0.5 h, diluted with EtOAc, and washed with water. The organic phase was concentrated to give the crude 3-((S)-1-((S)-1-(4-bromophenyl)ethyl)-4-(4-fluorophenyl)-2-oxopiperidin-4-yl)propanoic acid (28 mg, 90%), which was used for the next step without further purification.
Workup
- washwashed with water
- concentrationThe organic phase was concentrated
Sources & evidence
- ORD record
- ord-9a4a5c5792314995bebae6462e7b81f4
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08680281B2
Reaction notes
Loading…